Nine Chapters Capital Management’s Arcturus Therapeutics ARCT Stock Holding History

Nine Chapters Capital Management’s Portfolio ARCT Stock Details ARCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$13K	Buy	+1,857	New	+$14K	0.03%	152

Other funds holding ARCT

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

LCM

Leisure Capital Management Costa Mesa, California $320M AUM 39.11% 1-Year Est. Return

Nine Chapters Capital Management's ARCT Position: Q3 2017 in Review

Nine Chapters Capital Management opened a new position in Arcturus Therapeutics (ARCT) in Q3 2017: 1,857 shares worth $13K. The stake represents 0.03% of the portfolio and ranks #152 among its holdings.

24 funds tracked by Wall St. Rank hold ARCT as of Q3 2017.

Nine Chapters Capital Management held 1,857 shares of Arcturus Therapeutics worth $13K as of Q3 2017.
Arcturus Therapeutics was a new Nine Chapters Capital Management position in Q3 2017.
Arcturus Therapeutics made up 0.03% of Nine Chapters Capital Management's portfolio in Q3 2017, its #152 holding.
24 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2017.

Based on Nine Chapters Capital Management's 13F filing for Q3 2017, filed 31 Oct 2017.